It has been reported that regulation of AKT activity induces a cellular response to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) 33; AKT signaling is involved in the regulation of inflammation and tumor formation in bladder cancer; activation of AKT increases tumor cell resistance to paclitaxel 34. This evidence concerns the gene AKT1 and urinary bladder carcinoma.